Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Essence (BIOE) EBT Margin (2020 - 2025)

Bio Essence has reported EBT Margin over the past 6 years, most recently at 69.56% for Q4 2025.

  • Quarterly results put EBT Margin at 69.56% for Q4 2025, up 8824.0% from a year ago — trailing twelve months through Dec 2025 was 47.27% (up 37479.0% YoY), and the annual figure for FY2025 was 47.27%, up 53036.0%.
  • EBT Margin for Q4 2025 was 69.56% at Bio Essence, up from 9.5% in the prior quarter.
  • Over the last five years, EBT Margin for BIOE hit a ceiling of 89.25% in Q4 2023 and a floor of 927.27% in Q1 2025.
  • Median EBT Margin over the past 5 years was 61.67% (2022), compared with a mean of 145.84%.
  • Peak annual rise in EBT Margin hit 90006bps in 2025, while the deepest fall reached -84734bps in 2025.
  • Bio Essence's EBT Margin stood at 42.54% in 2021, then increased by 3bps to 41.19% in 2022, then skyrocketed by 317bps to 89.25% in 2023, then plummeted by -121bps to 18.68% in 2024, then surged by 472bps to 69.56% in 2025.
  • The last three reported values for EBT Margin were 69.56% (Q4 2025), 9.5% (Q3 2025), and 23.41% (Q2 2025) per Business Quant data.